Delivery Order SPE2DB24D2011-SPE2DB24FBRCZ

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award, valued at $2,813.43, is for the supply of a pharmaceutical product, specifically DUPIXENT 300 MG/2 ML PEN 2ML, to support military treatment programs and facilities. Amerisourcebergen Drug Corp has an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,577.31, is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has a period of performance through May 27, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a $9,914.10 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4565828592 DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a wide range of...
This is a $1,709.46 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DUPIXENT 300 MG/2 ML PEN 2ML. The contract has an ultimate completion date of May 29, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
This is a $3,304.72 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The order is for DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract has a completion date of September 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) to supply a wide range of medical commodities, including...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $13,655.88 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,184,849 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor. The IDC enables Amerisourcebergen to deliver a comprehensive range of...
This is a $39,507.26 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DUPIXENT 300 MG/2 ML PEN 2ML. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This is a $23,286.53 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides 4,566,593,485 units of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty medication, with a period of performance through December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,285.95 firm fixed-price delivery order is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $15,866.59 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML medication, with a performance period ending on June 6, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB24FBRCZ
    Delivery Order

This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $35,795.25 contract is for the supply of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. No set-aside designation was used. This delivery order is associated with an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. As one of the largest pharmaceutical distributors in the United States, Amerisourcebergen leverages its extensive supply chain network to deliver essential medications and medical supplies to various government agencies and healthcare programs, including military treatment facilities and veterans' hospitals.

Generated 12/13/24, 9:38 AM